PNC-27 Research Peptide

PNC-27 is an experimental synthetic research peptide designed around a specific region of the p53 protein together with a membrane-penetrating peptide sequence. It is primarily investigated as a research tool for studying p53/HDM-2 (MDM2)-related molecular interactions and mechanisms of cell death in selected cellular models.

In experimental cancer biology research, PNC-27 has been investigated in connection with HDM-2/MDM2-related signaling, tumor-cell membrane interactions, changes in membrane integrity, and cell-death processes. Preclinical studies have also explored its effects across different cancer cell models and the mechanisms that may contribute to cellular selectivity.

These characteristics make PNC-27 a research compound of interest for investigating p53/MDM2 biology, tumor-cell membrane mechanisms, cell death, and experimental cancer biology.

Research involving PNC-27 remains primarily experimental and preclinical. Findings from cellular or animal models should not be interpreted as established anti-cancer efficacy in humans, and PNC-27 should not be represented as an approved cancer treatment.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.